| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ANA.21719 |
| P698 | PubMed publication ID | 19798635 |
| P50 | author | Michael Tsokos | Q1929609 |
| Frauke Zipp | Q21259942 | ||
| Friedemann Paul | Q30353016 | ||
| Johannes Vogt | Q30504191 | ||
| Harry W M Steinbusch | Q55178235 | ||
| Cedric S Raine | Q96067895 | ||
| P2093 | author name string | Orhan Aktas | |
| Robert Nitsch | |||
| Christoph Schmitz | |||
| Jan Dörr | |||
| Robert Glumm | |||
| B Suman Bharathi | |||
| Kathrin Müller-Wielsch | |||
| Susanne Dörr | |||
| P2860 | cites work | Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis | Q34649942 |
| Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions | Q35745974 | ||
| P433 | issue | 3 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| experimental autoimmune encephalomyelitis | Q494066 | ||
| P304 | page(s) | 310-322 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Annals of Neurology | Q564414 |
| P1476 | title | Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. | |
| P478 | volume | 66 |
| Q48587582 | A Comparison of Magnetization Transfer Methods to Assess Brain and Cervical Cord Microstructure in Multiple Sclerosis |
| Q42847184 | A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. |
| Q33526913 | A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes |
| Q36128036 | Age-Related Uptake of Heavy Metals in Human Spinal Interneurons. |
| Q28477723 | Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways |
| Q40152964 | An increase in tolerogenic dendritic cell and natural regulatory T cell numbers during experimental autoimmune encephalomyelitis in Rras-/- mice results in attenuated disease. |
| Q92225228 | Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis |
| Q40217942 | Assessing sensory versus optogenetic network activation by combining (o)fMRI with optical Ca2+ recordings |
| Q57562094 | Axonal Loss and Neurofilament Phosphorylation Changes Accompany Lesion Development and Clinical Progression in Multiple Sclerosis |
| Q35126104 | Axonal damage in multiple sclerosis. |
| Q38071242 | Brain-derived neurotrophic factor in neuroimmunology: lessons learned from multiple sclerosis patients and experimental autoimmune encephalomyelitis models |
| Q34094705 | Bushen Yisui Capsule ameliorates axonal injury in experimental autoimmune encephalomyelitis. |
| Q36588696 | Can we prevent or treat multiple sclerosis by individualised vitamin D supply? |
| Q35675723 | Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination |
| Q49352569 | Cholinergic imbalance in lumbar spinal cord of a rat model of multiple sclerosis |
| Q38446276 | Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis |
| Q46403566 | Cladribine in multiple sclerosis: pitfalls in a new treatment landscape |
| Q43117005 | Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? |
| Q28364911 | Current automated 3D cell detection methods are not a suitable replacement for manual stereologic cell counting |
| Q48237058 | Design-Based Stereology for Evaluation of Histological Parameters |
| Q41680674 | Dissecting the effects of endogenous brain IL-2 and normal versus autoreactive T lymphocytes on microglial responsiveness and T cell trafficking in response to axonal injury |
| Q33862545 | Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitis |
| Q36648907 | Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases? |
| Q46008998 | Focal amyotrophy in multiple sclerosis. |
| Q44817678 | GEMSP exerts a myelin-protecting role in the rat optic nerve |
| Q35070023 | Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking |
| Q38272285 | Immune responses to non-tumor antigens in the central nervous system. |
| Q36750834 | Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis |
| Q37766302 | Inflammation in neurodegenerative diseases |
| Q36088247 | Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis |
| Q34405459 | Is metabolic flexibility altered in multiple sclerosis patients? |
| Q36007543 | K+ channel alterations in the progression of experimental autoimmune encephalomyelitis |
| Q91003394 | Liver kinase B1 depletion from astrocytes worsens disease in a mouse model of multiple sclerosis |
| Q35147178 | Loss of CNS IL-2 gene expression modifies brain T lymphocyte trafficking: response of normal versus autoreactive Treg-deficient T cells |
| Q48182960 | Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. |
| Q36590210 | Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death |
| Q91786481 | Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis |
| Q37800214 | Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis |
| Q28741362 | Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis |
| Q50092337 | Motor unit discharge characteristics and walking performance of individuals with multiple sclerosis. |
| Q38130445 | Multiple sclerosis: basic knowledge and new insights in perioperative management |
| Q41510304 | Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology? |
| Q48500909 | Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions. |
| Q35794898 | Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53 |
| Q22241472 | Neurodegeneration in multiple sclerosis: novel treatment strategies |
| Q37493548 | Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis |
| Q57039772 | Neuronal microRNA regulation in Experimental Autoimmune Encephalomyelitis |
| Q34055604 | Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation |
| Q57623524 | Neuroprotektion in der Therapie der Multiplen Sklerose |
| Q48393266 | Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations |
| Q52845476 | Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density. |
| Q48201071 | Peripheral nerve involvement in multiple sclerosis: Demonstration by magnetic resonance neurography |
| Q41992411 | Predictors of outcome in a large retrospective cohort of patients with transverse myelitis. |
| Q37598458 | Quantitative 3D investigation of Neuronal network in mouse spinal cord model. |
| Q37708381 | Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis |
| Q45788375 | Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome |
| Q39091396 | Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis |
| Q36127346 | Role of glial 14-3-3 gamma protein in autoimmune demyelination |
| Q42153853 | Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis |
| Q39138135 | Synaptic Phospholipid Signaling Modulates Axon Outgrowth via Glutamate-dependent Ca2+-mediated Molecular Pathways |
| Q87802296 | The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis |
| Q28740407 | The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis |
| Q57623514 | The problems and promises of research into human immunology and autoimmune disease |
| Q35082344 | The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis |
| Q87671063 | The role of TRAIL in fatigue induced by repeated stress from radiotherapy |
| Q35551001 | The role of environmental exposures in neurodegeneration and neurodegenerative diseases |
| Q26797409 | The unfolded protein response in multiple sclerosis |
| Q37403700 | Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis |
| Q38533728 | Type 1 narcolepsy: a CD8(+) T cell-mediated disease? |
| Q30454634 | What went wrong? The flawed concept of cerebrospinal venous insufficiency. |
| Q33919133 | X-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model. |
Search more.